{"id":23636,"date":"2023-05-10T13:00:47","date_gmt":"2023-05-10T18:00:47","guid":{"rendered":"https:\/\/cdtrp.ca\/en\/?post_type=spucpt&p=23636"},"modified":"2023-05-10T13:00:47","modified_gmt":"2023-05-10T18:00:47","slug":"denis-claude-roy","status":"publish","type":"spucpt","link":"https:\/\/cdtrp.ca\/en\/spucpt\/denis-claude-roy\/","title":{"rendered":"Denis-Claude Roy"},"content":{"rendered":"

Denis Claude Roy’s bio<\/strong><\/p>\n

\"\"<\/p>\n

Professor of medecine at the Universit\u00e9 de Montreal, Denis Claude Roy isFounder and Director of the Institut Universitaire d\u2019H\u00e9mato-Oncologie et de Th\u00e9rapie Cellulaire (IUHOTC), and Centre d\u2019excellence en th\u00e9rapie cellulaire (CETC), \u00e0 l\u2019H\u00f4pital Maisonneuve-Rosemont, CIUSSS-East-Island-of-Montr\u00e9al; CEO of CellCAN Canadian Regenerative Medicine and Cell Therapy Network for Knowledge Mobilization (Network of Centres of Excellence); and Chief Scientific Officer of C3i, the Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine. He is also co-director of Th\u00e9Cell, the Qu\u00e9bec Cell, Tissue and Gene Therapy Network of the Fonds de recherche du Qu\u00e9bec \u2013 Sant\u00e9.<\/p>\n

Trained in tumor immunology at the Dana-Farber Cancer Institute in Boston (USA), his translational and clinical research focuses on cell manipulation in order to improve the clinical impact of stem cells, cancer immunotherapy and regenerative medicine. The main objective of his work is to develop approaches to fight blood cancers and promote immune tolerance. He has chaired more than 15 Phase I, II and III cell therapy clinical trials at national and international levels. He has published over 130 original articles and book chapters in prestigious journals. He is developing a Good Manufacturing Practices (GMP) Gene Therapy Production Unit at the CETC.
\n______________________<\/p>\n

Professeur titulaire de m\u00e9decine \u00e0 l’Universit\u00e9 de Montr\u00e9al, Denis Claude Roy est Directeur de l\u2019Institut Universitaire d\u2019H\u00e9mato-Oncologie et de Th\u00e9rapie Cellulaire (IUHOTC) et du Centre d\u2019excellence en th\u00e9rapie cellulaire (CETC), \u00e0 l\u2019HMR, CIUSSS-Est-Ile-de-Montr\u00e9al; directeur g\u00e9n\u00e9ral de CellCAN, le r\u00e9seau canadien de m\u00e9decine r\u00e9g\u00e9n\u00e9rative et de th\u00e9rapie cellulaire pour la mobilisation des connaissances ; et directeur scientifique de C3i : le Centre de commercialisation de l\u2019immunoth\u00e9rapie du cancer et de la m\u00e9decine r\u00e9g\u00e9n\u00e9ratrice. Il est \u00e9galement codirecteur du r\u00e9seau qu\u00e9b\u00e9cois (FRQS) de Th\u00e9rapie cellulaire, tissulaire et g\u00e9nique – Th\u00e9Cell.<\/p>\n

Form\u00e9 en immunologie des tumeurs au Dana-Farber Cancer Institute \u00e0 Boston (USA), ses travaux de recherche translationnelle et clinique portent sur la manipulation cellulaire afin d\u2019am\u00e9liorer l\u2019impact clinique de la greffe de cellules souches, de l\u2019immunoth\u00e9rapie du cancer et de la m\u00e9decine r\u00e9g\u00e9n\u00e9ratrice. Ses travaux ont pour principal objectif de d\u00e9velopper des approches pour \u00e9liminer les cancers h\u00e9matologiques et favoriser la tol\u00e9rance immune post-greffe. Il a pr\u00e9sid\u00e9 plus de 15 essais cliniques de th\u00e9rapie cellulaire de phases I, II et III aux niveaux national et international. Il a publi\u00e9 plus de 130 articles originaux et chapitres de livres dans des revues prestigieuses. Il d\u00e9veloppe pr\u00e9sentement une unit\u00e9 de production de vecteurs viraux de niveau de \u00ab bonnes pratiques de fabrication \u00bb (GMP) au CETC.<\/p>\n","protected":false},"author":6,"template":"","class_list":["post-23636","spucpt","type-spucpt","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/spucpt\/23636"}],"collection":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/spucpt"}],"about":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/types\/spucpt"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/users\/6"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media?parent=23636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}